Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer

B Laere; P Rajan; H Gronberg; L Dirix; J Lindberg; M Mayrhofer; T Whitington; PJ van Dam; P Van Oyen; C Ghysel; J Ampe; P Ost; W Demey; L Hoela; D Schrijvers; B Brouwers; W Lybaert; E Everaert; D De Maeseneer; M Strijbos; A Bols; K Fransis; Nick Beije; I (Ineke) Kruijff; V Dam; A Brouwer; D Goossens; L Heyrman; G Van den Eynden; A Rutten; J Del Favero; M Rantalainen; Stefan Sleijfer; A Ullen; J Yachnin; S van Laere; L De Laere; T Develter; S Vantieghem; S Herman; G Coifs; V Lamotte; A Boumans; A Baitar; R Haeck; G Wallays

doi:10.1001/jamaoncol.2019.0869

Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer

B Laere, P Rajan, H Gronberg, L Dirix, J Lindberg, M Mayrhofer, T Whitington, PJ van Dam, P Van Oyen, C Ghysel, J Ampe, P Ost, W Demey, L Hoela, D Schrijvers, B Brouwers, W Lybaert, E Everaert, D De Maeseneer, M StrijbosA Bols, K Fransis, Nick Beije, I (Ineke) Kruijff, V Dam, A Brouwer, D Goossens, L Heyrman, G Van den Eynden, A Rutten, J Del Favero, M Rantalainen, Stefan Sleijfer, A Ullen, J Yachnin, S van Laere, L De Laere, T Develter, S Vantieghem, S Herman, G Coifs, V Lamotte, A Boumans, A Baitar, R Haeck, G Wallays

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1059-1061
Number of pages	3
Journal	JAMA Oncology
Volume	5
Issue number	7
DOIs	https://doi.org/10.1001/jamaoncol.2019.0869
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2019.0869

http://hdl.handle.net/1765/119395

Cite this

Laere, B., Rajan, P., Gronberg, H., Dirix, L., Lindberg, J., Mayrhofer, M., Whitington, T., van Dam, PJ., Van Oyen, P., Ghysel, C., Ampe, J., Ost, P., Demey, W., Hoela, L., Schrijvers, D., Brouwers, B., Lybaert, W., Everaert, E., De Maeseneer, D., ... Wallays, G. (2019). Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer. JAMA Oncology, 5(7), 1059-1061. https://doi.org/10.1001/jamaoncol.2019.0869

@article{477b6ce1d86f4281b92764b3adf343b8,

title = "Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer",

author = "B Laere and P Rajan and H Gronberg and L Dirix and J Lindberg and M Mayrhofer and T Whitington and {van Dam}, PJ and {Van Oyen}, P and C Ghysel and J Ampe and P Ost and W Demey and L Hoela and D Schrijvers and B Brouwers and W Lybaert and E Everaert and {De Maeseneer}, D and M Strijbos and A Bols and K Fransis and Nick Beije and Kruijff, {I (Ineke)} and V Dam and A Brouwer and D Goossens and L Heyrman and {Van den Eynden}, G and A Rutten and {Del Favero}, J and M Rantalainen and Stefan Sleijfer and A Ullen and J Yachnin and {van Laere}, S and {De Laere}, L and T Develter and S Vantieghem and S Herman and G Coifs and V Lamotte and A Boumans and A Baitar and R Haeck and G Wallays",

year = "2019",

doi = "10.1001/jamaoncol.2019.0869",

language = "Undefined/Unknown",

volume = "5",

pages = "1059--1061",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "7",

}

Laere, B, Rajan, P, Gronberg, H, Dirix, L, Lindberg, J, Mayrhofer, M, Whitington, T, van Dam, PJ, Van Oyen, P, Ghysel, C, Ampe, J, Ost, P, Demey, W, Hoela, L, Schrijvers, D, Brouwers, B, Lybaert, W, Everaert, E, De Maeseneer, D, Strijbos, M, Bols, A, Fransis, K, Beije, N, Kruijff, I, Dam, V, Brouwer, A, Goossens, D, Heyrman, L, Van den Eynden, G, Rutten, A, Del Favero, J, Rantalainen, M, Sleijfer, S, Ullen, A, Yachnin, J, van Laere, S, De Laere, L, Develter, T, Vantieghem, S, Herman, S, Coifs, G, Lamotte, V, Boumans, A, Baitar, A, Haeck, R & Wallays, G 2019, 'Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer', JAMA Oncology, vol. 5, no. 7, pp. 1059-1061. https://doi.org/10.1001/jamaoncol.2019.0869

TY - JOUR

T1 - Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer

AU - Laere, B

AU - Rajan, P

AU - Gronberg, H

AU - Dirix, L

AU - Lindberg, J

AU - Mayrhofer, M

AU - Whitington, T

AU - van Dam, PJ

AU - Van Oyen, P

AU - Ghysel, C

AU - Ampe, J

AU - Ost, P

AU - Demey, W

AU - Hoela, L

AU - Schrijvers, D

AU - Brouwers, B

AU - Lybaert, W

AU - Everaert, E

AU - De Maeseneer, D

AU - Strijbos, M

AU - Bols, A

AU - Fransis, K

AU - Beije, Nick

AU - Kruijff, I (Ineke)

AU - Dam, V

AU - Brouwer, A

AU - Goossens, D

AU - Heyrman, L

AU - Van den Eynden, G

AU - Rutten, A

AU - Del Favero, J

AU - Rantalainen, M

AU - Sleijfer, Stefan

AU - Ullen, A

AU - Yachnin, J

AU - van Laere, S

AU - De Laere, L

AU - Develter, T

AU - Vantieghem, S

AU - Herman, S

AU - Coifs, G

AU - Lamotte, V

AU - Boumans, A

AU - Baitar, A

AU - Haeck, R

AU - Wallays, G

PY - 2019

Y1 - 2019

U2 - 10.1001/jamaoncol.2019.0869

DO - 10.1001/jamaoncol.2019.0869

M3 - Article

VL - 5

SP - 1059

EP - 1061

JO - JAMA Oncology

JF - JAMA Oncology

SN - 2374-2437

IS - 7

ER -